Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy
Linzhuo Huang, Rui Xu, Weirong Li, et al.
Acta Biomaterialia (2023) Vol. 162, pp. 98-109
Closed Access | Times Cited: 18

Showing 18 citing articles:

Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma
Shaoping Jiang, Wenpei Li, Jun Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6445-6462
Closed Access | Times Cited: 13
Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy
Zixuan Zhao, Yuan Cao, Rui Xu, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 291-320
Open Access | Times Cited: 9
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8
The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response
Xuanyu Guo, Jiajun Song, Miao Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 5
Nano-Based Strategies Aiming at Tumor Microenvironment for Improved Cancer Therapy
Tianhui Liu, Changshun Lu, Xue Jiang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepatocellular Carcinoma
Shuo Yang, Shutong Li, Tianhua Li, et al.
ACS Applied Nano Materials (2025)
Closed Access
Nanotherapeutic strategies exploiting biological traits of cancer stem cells
Hongyu Wang, Wenjing Zhang, Yun Sun, et al.
Bioactive Materials (2025) Vol. 50, pp. 61-94
Closed Access
Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma
Shuhua Wei, Fenghua Wei, Mengyuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114798-114798
Open Access | Times Cited: 10
Sorafenib-induced macrophage extracellular traps via ARHGDIG/IL4/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma
Xiangbo Huang, Nan Yi, Pengfei Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression
Alyona B. Kuznetsova, Ekaterina Kolesova, Alessandro Parodi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 636-636
Open Access | Times Cited: 2
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy
Linzhuo Huang, Zhiquan Huang, Yuxuan Zhang, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5528-5550
Open Access | Times Cited: 2
Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy
Tongyi Shang, Xinying Yu, Yuan Gu, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126539-126539
Closed Access | Times Cited: 6
Research Progress of Nano-Drugs Remodeling TAMs for Enhancing Cancer Immunotherapy
湘雅 刘
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 11-20
Closed Access | Times Cited: 1
Nature-inspired protein mineralization strategies for nanoparticle construction: advancing effective cancer therapy
Yuan Cao, Rui Xu, Yixia Liang, et al.
Nanoscale (2024) Vol. 16, Iss. 29, pp. 13718-13754
Closed Access | Times Cited: 1
Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy
Rui Xu, Xiangya Liu, Yuxuan Zhang, et al.
Nano Letters (2024) Vol. 24, Iss. 28, pp. 8723-8731
Closed Access | Times Cited: 1
Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs via overcoming the hypoxia tumor microenvironment
Zhe Li, Jinshuai Lan, Ya Wu, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 157231-157231
Open Access | Times Cited: 1
Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
Ran Wei, Ou Qi Feng, Yao Ze Hui, et al.
Bioscience Reports (2023) Vol. 43, Iss. 7
Open Access | Times Cited: 2
Page 1

Scroll to top